Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs B cell lymphoma vaccine (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Sponsors XEME Biopharma
- 30 Jun 2017 Last checked against ClinicalTrials.gov record.
- 26 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Jun 2020.
- 26 Jun 2017 Planned primary completion date changed from 1 Jul 2018 to 1 May 2020.